Dr. Friedman participates in research to evaluate the cardiovascular transition from the fetus to the newborn. Dr. Friedman is working with members of the Section of Hematology and Oncology to evaluate the hemodynamic effects of Sickle Cell Disease in the outpatient setting. He is also working in...
Dr. Friedman participates in research to evaluate the cardiovascular transition from the fetus to the newborn. Dr. Friedman is working with members of the Section of Hematology and Oncology to evaluate the hemodynamic effects of Sickle Cell Disease in the outpatient setting. He is also working in a project that examines the effects of hyperphosphatemia on myocardial performance. Dr. Friedman is also active in novel and innovative methods of pediatric resident education and systems management.